worldwiki
intent.procedure

How is cell viability percentage calculated?

Published Sep 18, 2026Updated Oct 8, 2026Last verified Sep 18, 2026Requests recorded in this site’s own server logs, with the crawler identity checked by reverse DNS or IP range.Google25Meta20OpenAI9Anthropic5Parallel4Ahrefs2Apple1Microsoft1Perplexity1First collected Sep 19, 2026Recent requestsAhrefsOct 30, 2026MicrosoftOct 19, 2026Meta · unverifiedOct 12, 2026Meta · unverifiedOct 12, 2026Meta · unverifiedOct 12, 2026Meta · unverifiedOct 12, 2026AhrefsOct 9, 2026Meta · unverifiedOct 9, 2026OpenAIOct 6, 2026Meta · unverifiedOct 3, 2026Meta · unverifiedOct 3, 2026Meta · unverifiedOct 3, 2026
Request a correction
LanguagesEnglishWritten for this market; it is not a translation of another page.
Quick answer

Viability percentage = viable cells ÷ total cells counted × 100. With dye exclusion, unstained cells count as viable and stained cells as dead. This can be done manually on a hemocytometer or with an automated counter using trypan blue or AO/PI. The viable cell count, as an absolute number or concentration, is usually reported alongside the percentage, because a high percentage can still mean too few cells [2][3].

69 words9 sources

Answer

Plate-reader assays such as MTT, resazurin or ATP give a relative signal, not a per-cell percentage. They are usually expressed as a percentage of an untreated control [1].

Stem cells in cosmetic surgery

In cosmetic surgery, "stem cell" procedures almost always use adipose-derived stem cells. The stromal vascular fraction (SVF), which contains them, is separated from liposuctioned fat and mixed into the fat being grafted, as in stem cell breast augmentation and stem cell fat grafting.

Sources

  1. journalCell Viability Assays (Assay Guidance Manual) — National Center for Biotechnology Information (NCBI Bookshelf), Riss TL et al. · accessed Nov 10, 2026 · Evidence page
  2. journalChallenges of Cell Counting in Cell Therapy Products — Cell Transplantation (Liu M et al.) · accessed Nov 10, 2026 · Evidence page
  3. journalCAR T cell viability release testing and clinical outcomes: is there a lower limit? — Blood (Chong EA et al.), 134(21):1873–1875 · accessed Nov 10, 2026 · Evidence page
  4. journalQuality standards for NK cell immunotherapies — Frontiers in Bioengineering and Biotechnology (von Werz et al.) · accessed Nov 10, 2026 · Evidence page
  5. academicCell Viability – Flow Cytometry Facility — University of Toronto, Temerty Faculty of Medicine Flow Cytometry Facility · accessed Nov 10, 2026 · Evidence page
  6. journalPlasma membrane permeabilization following cell death: many ways to dye! — Cell Death Discovery (De Schutter E et al.) · accessed Nov 10, 2026 · Evidence page
  7. journalAssessing Adipocyte Viability and Surgeons' Work Efficiency by Comparing Different Liposuction Methods — Plastic and Reconstructive Surgery Global Open (Urbonas T et al.) · accessed Nov 10, 2026 · Evidence page
  8. journalQuantitative assessment of the impact of cryopreservation on human bone marrow-derived mesenchymal stem cells: up to 24 h post-thaw and beyond — Stem Cell Research & Therapy (Bahsoun S, Coopman K, Akam EC) · accessed Nov 10, 2026 · Evidence page
  9. governmentContent and Review of Chemistry, Manufacturing, and Control (CMC) Information for Human Somatic Cell Therapy Investigational New Drug Applications (INDs) — U.S. Food and Drug Administration · accessed Nov 12, 2026 · Evidence page